Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Pollard

Showing results (621-630 of 642) with videos related to

Pageof 65
Sort By:
BMJ (Clinical Research Ed.)|February 9, 2019
Arthroscopic hip surgery compared with physiotherapy and activity modification for the treatment of symptomatic femoroacetabular impingement: multicentre randomised controlled trialAntony J R Palmer, Vandana Ayyar Gupta, Scott Fernquest, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1996
Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDSP K Sharkey, J R Graybill, E S Johnson, et al.
Pharmacogenetics and Genomics|October 19, 2006
Multilocus genetic interactions and response to efavirenz-containing regimens: an adult AIDS clinical trials group studyAlison A Motsinger, Marylyn D Ritchie, Robert W Shafer, et al.
The Journal of Infectious Diseases|April 28, 2010
Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trialDavid M Asmuth, Robert L Murphy, Susan L Rosenkranz, et al.
The Journal of Infectious Diseases|June 7, 2003
Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumesRobert C Kalayjian, Alan Landay, Richard B Pollard, et al.
Translational Psychiatry|February 8, 2017
The MCP-4/MCP-1 ratio in plasma is a candidate circadian biomarker for chronic post-traumatic stress disorderC Dalgard, O Eidelman, C Jozwik, et al.
The Journal of Infectious Diseases|November 4, 2005
Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group StudyDavid W Haas, Laura M Smeaton, Robert W Shafer, et al.
Molecular & Cellular Proteomics : MCP|July 11, 2006
De novo biosynthetic profiling of high abundance proteins in cystic fibrosis lung epithelial cellsHarvey B Pollard, Ofer Eidelman, Catherine Jozwik, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 21, 2010
Raltegravir versus Efavirenz regimens in treatment-naive HIV-1-infected patients: 96-week efficacy, durability, subgroup, safety, and metabolic analysesJeffrey L Lennox, Edwin Dejesus, Daniel S Berger, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 26, 2011
Molecular characterization of stool microbiota in HIV-infected subjects by panbacterial and order-level 16S ribosomal DNA (rDNA) quantification and correlations with immune activationCollin L Ellis, Zhong-Min Ma, Surinder K Mann, et al.
Pageof 65

Showing results (621-630 of 642) with videos related to

Sort By:
Pageof 65
BMJ (Clinical Research Ed.)|February 9, 2019
Arthroscopic hip surgery compared with physiotherapy and activity modification for the treatment of symptomatic femoroacetabular impingement: multicentre randomised controlled trialAntony J R Palmer, Vandana Ayyar Gupta, Scott Fernquest, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1996
Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDSP K Sharkey, J R Graybill, E S Johnson, et al.
Pharmacogenetics and Genomics|October 19, 2006
Multilocus genetic interactions and response to efavirenz-containing regimens: an adult AIDS clinical trials group studyAlison A Motsinger, Marylyn D Ritchie, Robert W Shafer, et al.
The Journal of Infectious Diseases|April 28, 2010
Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trialDavid M Asmuth, Robert L Murphy, Susan L Rosenkranz, et al.
The Journal of Infectious Diseases|June 7, 2003
Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumesRobert C Kalayjian, Alan Landay, Richard B Pollard, et al.
Translational Psychiatry|February 8, 2017
The MCP-4/MCP-1 ratio in plasma is a candidate circadian biomarker for chronic post-traumatic stress disorderC Dalgard, O Eidelman, C Jozwik, et al.
The Journal of Infectious Diseases|November 4, 2005
Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group StudyDavid W Haas, Laura M Smeaton, Robert W Shafer, et al.
Molecular & Cellular Proteomics : MCP|July 11, 2006
De novo biosynthetic profiling of high abundance proteins in cystic fibrosis lung epithelial cellsHarvey B Pollard, Ofer Eidelman, Catherine Jozwik, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 21, 2010
Raltegravir versus Efavirenz regimens in treatment-naive HIV-1-infected patients: 96-week efficacy, durability, subgroup, safety, and metabolic analysesJeffrey L Lennox, Edwin Dejesus, Daniel S Berger, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 26, 2011
Molecular characterization of stool microbiota in HIV-infected subjects by panbacterial and order-level 16S ribosomal DNA (rDNA) quantification and correlations with immune activationCollin L Ellis, Zhong-Min Ma, Surinder K Mann, et al.
Pageof 65